Physician profile
Asma Mian
NPI 1649588229
$374.58
in general payments reported to CMS, 2019-2025
13 companies · $16.11 in 2025
The $16.11 reported for 2025 was less than what a typical Child & Adolescent Psychiatry provider received nationally (typical 2025 total: $132).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $260 · 2020: $51.21 · 2021: $13.91 · 2022: $33.61 · 2025: $16.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $65.89 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $42.11 | 2019 | |
| Neos Therapeutics, LP | $40.40 | 2019-2020 | |
| Shire North American Group INC | $40.10 | 2019 | |
| Allergan, INC. | $39.94 | 2019-2020 | |
| Abbvie INC. | $29.83 | 2022-2025 | |
| Otsuka America Pharmaceutical, INC. | $26.47 | 2019 | |
| Corium, LLC | $19.89 | 2022 | |
| Neuronetics, INC. | $16.66 | 2019 | |
| Rhodes Pharmaceuticals L.P. | $14.83 | 2019 | |
| Tris Pharma INC | $13.91 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.30 | 2020 | |
| Janssen Pharmaceuticals, INC | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asma Mian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.